| Erwin G Enriquez, MD | |
|
2025 Morse Ave, Sacramento, CA 95825-2115 | |
| (916) 973-5000 | |
| Not Available |
| Full Name | Erwin G Enriquez |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 26 Years |
| Location | 2025 Morse Ave, Sacramento, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295813913 | NPI | - | NPPES |
| 00A715850 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A71585 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Sacramento | Sacramento, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Children with mediastinal masses - tumors in their chest outside the lungs - are at special risk for developing breathing problems when they undergo anesthesia. These young patients are of special concern to clinicians who must anesthetize them as part of their medical treatment.
Rigel Pharmaceuticals, Inc. today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product candidates. R343 is an inhaled SYK inhibitor that is being evaluated as a potential treatment for allergic asthma.
For most teens, getting a tan during spring break or in preparation for the prom is as common as these rites of passage themselves. Although teens hear dermatologists' warnings that tanning is the most avoidable risk factor in the prevention of skin cancer, studies find they forgo this advice in favor of the bronzed look.
RetiPharma has secured funding from the Novo Nordisk Foundation's BioInnovation Institute to develop a new drug for degenerative eye disorders.
› Verified 8 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Children with mediastinal masses - tumors in their chest outside the lungs - are at special risk for developing breathing problems when they undergo anesthesia. These young patients are of special concern to clinicians who must anesthetize them as part of their medical treatment.
Rigel Pharmaceuticals, Inc. today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product candidates. R343 is an inhaled SYK inhibitor that is being evaluated as a potential treatment for allergic asthma.
For most teens, getting a tan during spring break or in preparation for the prom is as common as these rites of passage themselves. Although teens hear dermatologists' warnings that tanning is the most avoidable risk factor in the prevention of skin cancer, studies find they forgo this advice in favor of the bronzed look.
RetiPharma has secured funding from the Novo Nordisk Foundation's BioInnovation Institute to develop a new drug for degenerative eye disorders.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erwin G Enriquez, MD 1800 Harrison St Fl 7, Oakland, CA 94612-3466 Ph: (510) 625-6262 | Erwin G Enriquez, MD 2025 Morse Ave, Sacramento, CA 95825-2115 Ph: (916) 973-5000 |
News Archive
Children with mediastinal masses - tumors in their chest outside the lungs - are at special risk for developing breathing problems when they undergo anesthesia. These young patients are of special concern to clinicians who must anesthetize them as part of their medical treatment.
Rigel Pharmaceuticals, Inc. today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product candidates. R343 is an inhaled SYK inhibitor that is being evaluated as a potential treatment for allergic asthma.
For most teens, getting a tan during spring break or in preparation for the prom is as common as these rites of passage themselves. Although teens hear dermatologists' warnings that tanning is the most avoidable risk factor in the prevention of skin cancer, studies find they forgo this advice in favor of the bronzed look.
RetiPharma has secured funding from the Novo Nordisk Foundation's BioInnovation Institute to develop a new drug for degenerative eye disorders.
› Verified 8 days ago
Elizabeth Johnson, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-8570 | |
Timothy Sturgill, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7500 Hospital Dr, Sacramento, CA 95823 Phone: 330-493-4443 | |
Jon Haynes, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-8570 Fax: 916-734-7950 | |
Mark Portman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd., Sacramento, CA 95817 Phone: 916-734-8570 Fax: 916-734-7950 | |
Juliette Gerardo, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2315 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-2011 | |
Dr. John Ray Richards, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2315 Stockton Blvd, Pssb 2100 Emergency Medicine, Sacramento, CA 95817 Phone: 916-734-1537 Fax: 916-734-7950 | |
Kerilee Wenker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2801 L St, Sacramento, CA 95816 Phone: 916-454-2222 |